These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19569185)

  • 1. Ligand shape emerges in solvent dipole ordering region at ligand binding site of protein.
    Murata K; Nagata N; Nakanishi I; Kitaura K
    J Comput Chem; 2010 Mar; 31(4):791-6. PubMed ID: 19569185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDOVS: a solvent dipole ordering-based method for virtual screening.
    Murata K; Nagata N; Nakanishi I; Kitaura K
    J Comput Chem; 2010 Nov; 31(15):2714-22. PubMed ID: 20839298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP.
    Zacharias M
    Proteins; 2004 Mar; 54(4):759-67. PubMed ID: 14997571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational automatic search method for stable docking models of protein and ligand.
    Mizutani MY; Tomioka N; Itai A
    J Mol Biol; 1994 Oct; 243(2):310-26. PubMed ID: 7932757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
    Popov VM; Yee WA; Anderson AC
    Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, and 3-way factor analysis.
    Dunn WJ; Hopfinger AJ; Catana C; Duraiswami C
    J Med Chem; 1996 Nov; 39(24):4825-32. PubMed ID: 8941396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards understanding the mechanisms of molecular recognition by computer simulations of ligand-protein interactions.
    Verkhivker GM; Rejto PA; Bouzida D; Arthurs S; Colson AB; Freer ST; Gehlhaar DK; Larson V; Luty BA; Marrone T; Rose PW
    J Mol Recognit; 1999; 12(6):371-89. PubMed ID: 10611647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking of balanol to dynamics snapshots of protein kinase A.
    Wong CF; Kua J; Zhang Y; Straatsma TP; McCammon JA
    Proteins; 2005 Dec; 61(4):850-8. PubMed ID: 16245317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a genetic algorithm for flexible docking.
    Jones G; Willett P; Glen RC; Leach AR; Taylor R
    J Mol Biol; 1997 Apr; 267(3):727-48. PubMed ID: 9126849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple active site corrections for docking and virtual screening.
    Vigers GP; Rizzi JP
    J Med Chem; 2004 Jan; 47(1):80-9. PubMed ID: 14695822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3D QSAR model of 17beta-HSD1 inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core applying molecular dynamics simulations and ligand-protein docking.
    Karkola S; Lilienkampf A; Wähälä K
    ChemMedChem; 2008 Mar; 3(3):461-72. PubMed ID: 18224704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand mapping on protein surfaces by the 3D-RISM theory: toward computational fragment-based drug design.
    Imai T; Oda K; Kovalenko A; Hirata F; Kidera A
    J Am Chem Soc; 2009 Sep; 131(34):12430-40. PubMed ID: 19655800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions.
    Abu Hammad AM; Afifi FU; Taha MO
    J Mol Graph Model; 2007 Sep; 26(2):443-56. PubMed ID: 17360207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
    Lee JH; Kang NS; Yoo SE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a MIP-based alignment and docking in computer-aided drug design.
    Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J
    Proteins; 2004 Aug; 56(3):585-94. PubMed ID: 15229890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.